A Smarter CRO Partner for Growing Biotech Companies

Specialist early-phase CRO for Phase I–II trials across Australia and New Zealand — delivering senior-led execution, faster timelines, and full transparency.

Your first clinical trial is a defining moment.

A single delay can impact your funding. The wrong partner can cost you months — and with the wrong CRO, you're often navigating layers, turnover, and rising costs when precision matters most.

Why Traditional CRO Models Fail Early-Stage Biotechs

Most CROs are built for scale, not for early-phase execution.
That creates real risk for early-stage biotech:

1

Multiple layers slowing down decisions

2

Junior teams managing critical milestones

3

Generic processes that don't fit early-phase reality

4

Budget creep, delayed first-patient-in

Early-phase trials are make-or-break for small biotechs.

Most don't fail because of the science.

They fail because of execution.

Book a 30-Minute Early Phase Strategy Call

Your first clinical trial is a defining moment.

“What clinical trial partner means to me is a strong collaboration where we become an extension of your business, not just a vendor you check in with.”
‍

- Negin Rahmani Founder

A CRO Model Built for Emerging and Growing Biotechs

We partner with biotech companies supporting first-in-human trials, accelerating toward proof-of-concept, and scaling programs following promising early data. We combine senior oversight, lean execution, and flexible delivery to give you speed, control, and clarity when it matters most.

Large CROs often rely on junior teams, layered hand-offs, and rigid processes. We've flipped the model.

Senior-Led Execution

No layers. No handoffs. Every study is led by experienced operators who understand early-phase complexity, from CTN submissions to HREC approvals and Phase I unit delivery across ANZ.

Built for Speed

Built for speed, not bureaucracy. Our modular team structure adapts to your study, enabling faster decisions without the weight of traditional CRO models.

Cost Efficient by Design

Clarity from day one. Pay only for what you need — no hidden overhead, no unnecessary management layers, and no surprise change orders.

What This Means for Your Trial

Combining our unique Clinical Trial Partnership model with the Australian Advantage means:
  • Site activation in ~6–8 weeks (study-dependent)
  • 30–50% cost efficiencies through lean delivery
  • Access to Australia’s R&D tax incentive (up to 43.5%)

Faster start. Smarter spending. Stronger execution.

Global Reach, Local Insight

Based in Australia and growing presence across the U.S. and Asia, we support global programs by acting as the regional partner for early phase trials across ANZ. Our team works across time zones and cultures with ease, giving you a partner who thinks globally, and acts quickly.

What We Offer

Clinical Operation

Tailored services according to the trial requirements.

Learn more

Biometrics

High-quality and timely biostatistics services.

Learn more

Medical Affairs

Medical expertise during the trial lifecycle.

Learn more

Local Sponsorship

Local sponsor services offering significant cost savings.

Learn more

Pharmacovigilance

Expert drug safety monitoring every step of the way.

Learn more

Regulatory Affairs

Charting an efficient path for the success of the drug.

Learn more

Book a Free 30-Minute Early Phase Strategy Call with founder, Negin Rahmani

BOOK NOW